Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in COVID-19 Pneumonia
NCT05094596Phase 4Unknown
- Start
- Oct 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of montelukast in COVID-19 pneumonia. Status: unknown.
02
Drugs
montelukast
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT05094596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05094596.